Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
March 19, 2014	3	Initial filing by director officer or owner of more than ten percent.	0001209191-14-022042.pdf 0001209191-14-022042.rtf 0001209191-14-022042.xls View HTML
March 19, 2014	3	Initial filing by director officer or owner of more than ten percent.	0001209191-14-022041.pdf 0001209191-14-022041.rtf 0001209191-14-022041.xls View HTML
March 19, 2014	3	Initial filing by director officer or owner of more than ten percent.	0001209191-14-022043.pdf 0001209191-14-022043.rtf 0001209191-14-022043.xls View HTML
March 19, 2014	EFFECT	EFFECT	9999999995-14-000699.pdf 9999999995-14-000699.rtf 9999999995-14-000699.xls View HTML
March 21, 2014	424B4	Form of prospectus disclosing information facts events covered in both forms 424B1 424B3	0001193125-14-110516.pdf 0001193125-14-110516.rtf 0001193125-14-110516.xls View HTML
March 25, 2014	CT ORDER	CT ORDER	9999999997-14-004310.pdf View HTML
March 26, 2014	4	Statement of changes in beneficial ownership of securities	0001209191-14-023241.pdf 0001209191-14-023241.rtf 0001209191-14-023241.xls View HTML
March 27, 2014	4	Statement of changes in beneficial ownership of securities	0001209191-14-023437.pdf 0001209191-14-023437.rtf 0001209191-14-023437.xls View HTML
March 27, 2014	4	Statement of changes in beneficial ownership of securities	0001209191-14-023438.pdf 0001209191-14-023438.rtf 0001209191-14-023438.xls View HTML
March 27, 2014	4	Statement of changes in beneficial ownership of securities	0001209191-14-023436.pdf 0001209191-14-023436.rtf 0001209191-14-023436.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax